Objective: Biotransformation of triazolam to its alpha-hydroxy and 4-hydroxy metabolites by human liver microsomes in vitro was used as an index of human cytochrome P450 3A (CYP3A) activity.
Results: The reaction was strongly inhibited by co-incubation with the viral protease inhibitors ritonavir (IC50 = 0.14 microM) and amprenavir (IC50 = 2.5 2.9 microM), and by the azole derivative ketoconazole (IC50 = 0.07 microM). Pre-incubation of microsomes with ritonavir or amprenavir increased inhibitory potency (IC50 reduced to 0.07 microM and 1.4 microM, respectively). This was not the case with ketoconazole.
Conclusions: Thus, ritonavir and amprenavir are highly potent mechanism-based inhibitors of human CYP3A isoforms.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s002280000125 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Formulation, Development, and Optimization of Fast Dissolving Tablets Containing Tapentadol Hydrochloride.
Pharm Nanotechnol
December 2024
M.M. College of Pharmacy, Maharishi Markandeshwar Deemed to be University, Mullana- 133203, Ambala, India.
Background: Tapentadol hydrochloride is a potent analgesic commonly used to manage moderate to severe pain. Rapidly dissolving tablets of Tapentadol offer a significant advantage in enhancing patient compliance by providing quick pain relief. The development of fast-dissolving tablets (FDTs) requires careful consideration of formulation parameters to achieve optimal disintegration and dissolution profiles.
View Article and Find Full Text PDFTackling the unyielding: testing two novel approaches against NDM-producing Enterobacterales and isolates collected in India.
Microbiol Spectr
January 2025
Department of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.
Article Synopsis
- This study tested two new antibiotics, cefiderocol and cefepime/zidebactam, against NDM-producing Enterobacterales in India, aiming to address challenges posed by metallo-β-lactamases.
- Cefiderocol showed limited effectiveness, with variable susceptibility rates, while cefepime/zidebactam showed high susceptibility (≥90%) across the tested isolates.
- The research highlights the need for new treatment options for infections caused by carbapenem-resistant bacteria, particularly with the dominance of NDM in the region.
Crystal structure of β-d-galactofuranosidase from Streptomyces sp. JHA19 in complex with an inhibitor provides insights into substrate specificity.
FEBS Lett
December 2024
Department of Biotechnology, The University of Tokyo, Japan.
d-Galactofuranose (Galf) is widely distributed in glycoconjugates of pathogenic microbes. β-d-Galactofuranosidase (Galf-ase) from Streptomyces sp. JHA19 (ORF1110) belongs to glycoside hydrolase (GH) family 2 and is the first identified Galf-specific degradation enzyme.
View Article and Find Full Text PDFBiological activities of benzofurans from the fruits of Psoralea corylifolia L. and their mechanism based on network pharmacology and biological verification.
Phytochemistry
February 2025
Development and Utilization Key Laboratory of Northeast Plant Materials, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China. Electronic address:
Article Synopsis
- * These compounds were tested for antioxidant, anti-tumor, and anti-inflammatory properties, with benzofuran showing notable anti-inflammatory effects, particularly Compound 2 which outperformed a standard drug.
- * The anti-inflammatory action of Compound 2 was studied using network pharmacology, revealing that it works by activating the TLR4/NF-κB pathway, contributing to the understanding of benzofuran glycosides in medicine.*
Mechanism-based inactivators of sirtuin 5: A focused structure-activity relationship study.
Bioorg Med Chem Lett
January 2025
Center for Biopharmaceuticals & Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 160, DK-2100 Copenhagen, Denmark. Electronic address:
Sirtuin 5 (SIRT5) is a lysine deacylase enzyme that cleaves negatively charged ε-N-acyllysine posttranslational modifications, arising from short dicarboxylic acids. Inhibition of SIRT5 has been suggested as a target for treatment of leukemia and breast cancer. In this work, we performed a focused structure-activity relationship study that identified highly potent inhibitors of SIRT5.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!